Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crispr Therapeutics Ag
(NQ:
CRSP
)
55.56
-2.40 (-4.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Crispr Therapeutics Ag
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
3 Magnificent Stocks That Could Double or More by 2030
April 13, 2024
There's no guarantee these stocks will double by 2030, but their growth prospects look great.
Via
The Motley Fool
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
April 11, 2024
In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.
Via
InvestorPlace
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
April 09, 2024
These rising drugmakers have serious arguments in their favor.
Via
The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
April 09, 2024
These stocks, a bargain today, are players to hold on to for the long term.
Via
The Motley Fool
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
April 05, 2024
These companies are in the early days of their growth stories.
Via
The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,000 Today
March 19, 2024
Via
Benzinga
Is It Too Late to Buy CRISPR Therapeutics Stock?
March 16, 2024
The biotech has been making a lot of noise since late last year.
Via
The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
February 23, 2024
Via
Benzinga
3 Unstoppable Stocks to Buy Hand Over Fist in April
March 30, 2024
These stocks have exceptionally bright prospects.
Via
The Motley Fool
Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why
March 28, 2024
The company is working to launch its Vertex-partnered gene-editing drug for sickle cell disease and beta thalassemia.
Via
Investor's Business Daily
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
March 28, 2024
Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine.
Via
InvestorPlace
3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
March 27, 2024
Each of these three companies are entering a new era of growth.
Via
The Motley Fool
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
March 23, 2024
The price could be right for these three biopharma stocks.
Via
The Motley Fool
3 Stocks That Could Be the Next Big Thing in Gene Editing
March 21, 2024
Gene editing could revolutionize how millions of patients are treated. That could create big opportunities for gene-editing stocks.
Via
InvestorPlace
The 3 Most Undervalued Cathie Wood Stocks to Buy in March 2024
March 15, 2024
These undervalued Cathie Wood stocks capture her favorite trends and remain undervalued even as the wider tech sector surge.
Via
InvestorPlace
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.
Via
InvestorPlace
Cathie Wood's Ark Invest Keeps Dumping Coinbase Shares Amid Bitcoin, Crypto Buzz
March 12, 2024
On Tuesday, Cathie Wood-led Ark Invest made a significant move by offloading a substantial number of shares in Coinbase Global Inc (NASDAQ:COIN), despite Bitcoin (CRYPTO: BTC) reaching new
Via
Benzinga
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
March 11, 2024
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.
Via
Talk Markets
The Top 3 Biotech Stocks to Buy in March 2024
March 06, 2024
Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors.
Via
InvestorPlace
Here's Why CRISPR Therapeutics Stock Climbed 34% in February
March 05, 2024
The biotech company keeps moving closer to bringing its promising first gene therapy to market.
Via
The Motley Fool
ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential
March 04, 2024
Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
CRISPR Therapeutics Stock Has 32% Upside, According to 1 Wall Street Analyst
February 29, 2024
This company's fortunes are likely to improve, and soon.
Via
The Motley Fool
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
February 29, 2024
The futures for these two beaten-down stocks could be brighter than their recent pasts.
Via
The Motley Fool
Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug
February 27, 2024
Both companies are working on treatments for genetic disorders.
Via
Investor's Business Daily
3 Biotech Stocks Bound to Blast Off By 2029
February 27, 2024
Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years.
Via
InvestorPlace
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
February 27, 2024
Vertex shares have climbed almost 50% over the past year.
Via
The Motley Fool
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices
February 26, 2024
Latest pharmaceutical trends in the U.S. as drug prices surged 35% in 2023. Uncover insights into the industry's focus on rare diseases, escalating costs, and the impact on FDA-approved drugs.
Via
Benzinga
3 Biotech Stocks to Buy and Hold for the Next 10 Years
February 26, 2024
There's a lot to like about these three drugmakers right now, and that shouldn't stop anytime soon.
Via
The Motley Fool
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
February 26, 2024
Buy this stock if you're daring, but avoid it for now if you aren't.
Via
The Motley Fool
Three S&P 500 Giants Lead This List Of Stocks Near Buy Points
February 24, 2024
Watch these five stocks, but the market is slightly extended.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.